SJ-103

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSJ-103
Drug Alias NameSJ-103beta
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSillajen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSillajen Inc
Active IndicationsN/A
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A